To better understand the clinical effectiveness of therapies used in treating relapsed/refractory multiple myeloma (MM) in the real-world clinical practice.
To compare the efficacy of 2 different treatments in patients with Chronic Phase CML as measured by major molecular response (MMR) rate at 12 months.
To describe the clinical burden, healthcare resource utilization, complications, practice patterns, and therapy strategies in patients treated for PV in academic & community clinical practices within the United States.
To demonstrate the overall survival of subjects receiving a single agent for Chemo-Induced Anemia in Stage IV Non-small Cell Lung Cancer patients.
To assess the efficacy and safety of iron chelation therapy with a single agent compared to placebo in patients with myelodysplastic syndromes (MDS) (low/int-1 risk) and transfusional iron overload.
To compare the oncologic outcomes (local control, regional control, distant control, disease-free survival, cause-specific survival, overall survival) and rate of toxicities (frequency of symptoms) for patients diagnosed with a cancer in the chest or female reproductive tract.
To compare the effects of performing a standard lymph node removal versus an extended lymph node removal.